ROCKVILLE, Md., April 22, 2011 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical
company focused on the development and commercialization of
products for central nervous system disorders, today announced it
will release results for the first quarter of 2011, on Thursday, May 5, 2011, before the market opens. A
full text copy of the release will be disseminated at that
time.
Mihael H. Polymeropoulos, M.D.,
President and Chief Executive Officer, will host a conference call
to discuss the results at 10:00 AM ET
on Thursday, May 5, 2011. Also
participating on the call will be James
Kelly, Senior Vice President and Chief Financial Officer.
To participate in the conference call, dial the appropriate
number below shortly before the 10:00
AM start time and ask for the Vanda Pharmaceuticals
conference call hosted by Dr. Polymeropoulos.
|
The teleconference dial-in
numbers are as follows:
|
|
|
Domestic callers
1-866-383-7998
|
|
|
International callers
1-617-597-5329
|
|
|
Participant Passcode
44118664
|
|
|
The conference call will be broadcast simultaneously and
archived on the Company's website, www.vandapharma.com. Investors
should go to the website at least 15 minutes early to register,
download, and install any necessary audio software.
A replay of the call will be available on Thursday, May 5, 2011, beginning at 1:00 PM ET and will be accessible until
Thursday, May 12, 2011, at
5:00 PM ET. The replay call-in number
is 1-888-286-8010 for domestic callers and 1-617-801-6888 for
international callers. The access number is 73214212.
ABOUT VANDA PHARMACEUTICALS INC.:
Vanda Pharmaceuticals Inc. is a biopharmaceutical company
focused on the development and commercialization of products for
central nervous system disorders. For more on Vanda
Pharmaceuticals Inc., please visit http://www.vandapharma.com.
Company Contact:
Cristina Murphy
Communications Manager
Vanda Pharmaceuticals Inc.
(240) 599-4500
cristina.murphy@vandapharma.com
SOURCE Vanda Pharmaceuticals Inc.